Toxicology and Immunotoxicology

The Toxicology and Immunotoxicology Unit is concerned with planning and conducting preclinical efficacy and safety studies for new drug candidates and advanced therapy medicinal products (ATMPs). These trials are carried out under GLP or GLP-analogous conditions, in accordance with the applicable guidelines. The unit’s work involves developing, establishing and validating new in-vitro and in-vivo models for inflammatory and tumorigenic diseases. Please refer to the central facility GLP Test Facility for more information.

Our focus areas

• Planning and conducting preclinical studies
• Performing clinical chemistry, hematology and immunodiagnostics analyses
• Establishing and transferring special disease models
• Implementing new methods in the GLP system
• Conducting development-related safety and efficacy studies